Table 1.
Relationship between LNCAROD expression levels and clinicopathological parameters of HNSCC.
| Variable | No. of patient | LNCAROD expression (%) | P value | |
|---|---|---|---|---|
| High expression | Low expression | |||
| Age (year) | ||||
| > 60 | 254 | 181 (71.3) | 73 (28.7) | |
| ≤ 60 | 244 | 166 (68) | 78 (32) | 0.246 |
| Sex | ||||
| Female | 133 | 97 (72.9) | 36 (27.1) | |
| Male | 366 | 250 (68.3) | 116 (31.7) | 0.189 |
| Histological grade (WHO) | ||||
| G1–2 | 360 | 268 (74.4) | 92 (25.6) | |
| G3–4 | 120 | 74 (61.7) | 46 (38.3) | 0.006 |
| Clinical stage | ||||
| I + II + III | 195 | 137 (70.3) | 58 (29.7) | |
| IV | 304 | 210 (69.1) | 94 (30.9) | 0.430 |
| pT status | ||||
| T1–2 | 177 | 112 (63.3) | 65 (36.7) | |
| T3–4 | 312 | 227 (72.8) | 85 (27.2) | 0.019 |
| Lymph node metastasis | ||||
| No metastasis | 241 | 175 (72.6) | 66 (27.4) | |
| Metastasis | 240 | 157 (65.4) | 83 (34.6) | 0.054 |
| Distant metastasis | ||||
| No metastasis | 475 | 332 (69.9) | 143 (30.1) | |
| Metastasis | 5 | 3 (60) | 2 (40) | 0.477 |